|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
William WN Jr, Lin HY, Lee JJ, Lippman SM,
Roth JA and Kim ES: Revisiting stage IIIB and IV non-small cell
lung cancer: analysis of the Surveillance, Epidemiology, and End
Results data. Chest. 136:701–709. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taha TA, Hannun YA and Obeid LM:
Sphingosine kinase: biochemical and cellular regulation and role in
disease. J Biochem Mol Biol. 39:113–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spiegel S and Milstien S:
Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol
Cell Biol. 4:397–407. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu H, Chakravarty D, Maceyka M, Milstien
S and Spiegel S: Sphingosine kinases: a novel family of lipid
kinases. Prog Nucleic Acid Res Mol Biol. 71:493–511. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shida D, Takabe K, Kapitonov D, Milstien S
and Spiegel S: Targeting SphK1 as a new strategy against cancer.
Curr Drug Targets. 9:662–673. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cuvillier O, Ader I, Bouquerel P, et al:
Activation of sphingosine kinase-1 in cancer: implications for
therapeutic targeting. Curr Mol Pharmacol. 3:53–65. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li W, Yu CP, Xia JT, et al: Sphingosine
kinase 1 is associated with gastric cancer progression and poor
survival of patients. Clin Cancer Res. 15:1393–1399. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan SS, Khin LW, Wong L, et al:
Sphingosine kinase 1 promotes malignant progression in colon cancer
and independently predicts survival of patients with colon cancer
by competing risk approach in South Asian population. Clin Transl
Gastroenterol. 5:e512014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malavaud B, Pchejetski D, Mazerolles C, et
al: Sphingosine kinase-1 activity and expression in human prostate
cancer resection specimens. Eur J Cancer. 46:3417–3424. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruckhäberle E, Rody A, Engels K, et al:
Microarray analysis of altered sphingolipid metabolism reveals
prognostic significance of sphingosine kinase 1 in breast cancer.
Breast Cancer Res Treat. 112:41–52. 2008. View Article : Google Scholar
|
|
12
|
Yang YL, Ji C, Cheng L, et al: Sphingosine
kinase-1 inhibition sensitizes curcumin-induced growth inhibition
and apoptosis in ovarian cancer cells. Cancer Sci. 103:1538–1545.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dayon A, Brizuela L, Martin C, et al:
Sphingosine kinase-1 is central to androgen-regulated prostate
cancer growth and survival. PLoS One. 4:e80482009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nagahashi M, Ramachandran S, Kim EY, et
al: Sphingosine-1-phosphate produced by sphingosine kinase 1
promotes breast cancer progression by stimulating angiogenesis and
lymphangiogenesis. Cancer Res. 72:726–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan J, Tao YF, Zhou Z, et al: A novel role
of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of
esophageal carcinoma. J Transl Med. 9:1572011. View Article : Google Scholar
|
|
16
|
Song L, Xiong H, Li J, et al: Sphingosine
kinase-1 enhances resistance to apoptosis through activation of
PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin
Cancer Res. 17:1839–1849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guan H, Song L, Cai J, et al: Sphingosine
kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to
apoptosis resistance in glioma cells. PLoS One. 6:e199462011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pyne S, Lee SC, Long J and Pyne NJ: Role
of sphingosine kinases and lipid phosphate phosphatases in
regulating spatial sphingosine 1-phosphate signalling in health and
disease. Cell Signal. 21:14–21. 2009. View Article : Google Scholar
|
|
19
|
Meng XD, Zhou ZS, Qiu JH, Shen WH, Wu Q
and Xiao J: Increased SPHK1 expression is associated with poor
prognosis in bladder cancer. Tumour Biol. 35:2075–2080. 2014.
View Article : Google Scholar
|
|
20
|
Bayerl MG, Bruggeman RD, Conroy EJ, et al:
Sphingosine kinase 1 protein and mRNA are overexpressed in
non-Hodgkin lymphomas and are attractive targets for novel
pharmacological interventions. Leuk Lymphoma. 49:948–954. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fuereder T, Hoeflmayer D, Jaeger-Lansky A,
et al: Sphingosine kinase 1 is a relevant molecular target in
gastric cancer. Anticancer Drugs. 22:245–252. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nava VE, Hobson JP, Murthy S, Milstien S
and Spiegel S: Sphingosine kinase type 1 promotes
estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp
Cell Res. 281:115–127. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guan H, Liu L, Cai J, et al: Sphingosine
kinase 1 is overexpressed and promotes proliferation in human
thyroid cancer. Mol Endocrinol. 25:1858–1866. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu SQ, Su YJ, Qin MB, Mao YB, Huang JA
and Tang GD: Sphingosine kinase 1 promotes tumor progression and
confers malignancy phenotypes of colon cancer by regulating the
focal adhesion kinase pathway and adhesion molecules. Int J Oncol.
42:617–626. 2013.
|
|
25
|
Sarkar S, Maceyka M, Hait NC, et al:
Sphingosine kinase 1 is required for migration, proliferation and
survival of MCF-7 human breast cancer cells. FEBS Lett.
579:5313–5317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu SQ, Huang JA, Qin MB, et al:
Sphingosine kinase 1 enhances colon cancer cell proliferation and
invasion by upregulating the production of MMP-2/9 and uPA via MAPK
pathways. Int J Colorectal Dis. 27:1569–1578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bao M, Chen Z, Xu Y, et al: Sphingosine
kinase 1 promotes tumour cell migration and invasion via the
S1P/EDG1 axis in hepatocellular carcinoma. Liver Int. 32:331–338.
2012. View Article : Google Scholar
|
|
28
|
Zhang H, Wang Q, Zhao Q and Di W: MiR-124
inhibits the migration and invasion of ovarian cancer cells by
targeting SphK1. J Ovarian Res. 6:842013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kawahara S, Otsuji Y, Nakamura M, et al:
Sphingosine kinase 1 plays a role in the upregulation of CD44
expression through extracellular signal-regulated kinase signaling
in human colon cancer cells. Anticancer Drugs. 24:473–483. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kapitonov D, Allegood JC, Mitchell C, et
al: Targeting sphingosine kinase 1 inhibits Akt signaling, induces
apoptosis, and suppresses growth of human glioblastoma cells and
xenografts. Cancer Res. 69:6915–6923. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang H, Gao M, Shen Z, et al: Blocking
PI3K/Akt signaling attenuates metastasis of nasopharyngeal
carcinoma cells through induction of mesenchymal-epithelial
reverting transition. Oncol Rep. 32:559–566. 2014.PubMed/NCBI
|
|
32
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
